Tumor angiogenic vasculature targeting with PAMAM dendrimer-RGD conjugates.

PAMAM dendrimer-RGD-4C peptide conjugate was synthesized and in vitro targeting efficacy to integrin receptor expressing cells was studied by flow cytometry and confocal microscopy.

[1]  Erkki Ruoslahti,et al.  αv Integrins as receptors for tumor targeting by circulating ligands , 1997, Nature Biotechnology.

[2]  Anil K Patri,et al.  Dendritic polymer macromolecular carriers for drug delivery. , 2002, Current opinion in chemical biology.

[3]  H. Ghandehari,et al.  Targeting tumor angiogenic vasculature using polymer-RGD conjugates. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[4]  D. Cheresh,et al.  Requirement of vascular integrin alpha v beta 3 for angiogenesis. , 1994, Science.

[5]  David J Singel,et al.  Altering the strength of lectin binding interactions and controlling the amount of lectin clustering using mannose/hydroxyl-functionalized dendrimers. , 2003, Journal of the American Chemical Society.

[6]  E Ruoslahti,et al.  Solution structures and integrin binding activities of an RGD peptide with two isomers. , 2001, Biochemistry.

[7]  E. Voest,et al.  The potential role of antivascular therapy in the adjuvant and neoadjuvant treatment of cancer. , 2001, Seminars in oncology.

[8]  T. Kissel,et al.  Integrin targeting using RGD‐PEI conjugates for in vitro gene transfer , 2003, The journal of gene medicine.

[9]  P. Heegaard,et al.  Dendrimers in drug research. , 2004, Chemical Society reviews.

[10]  E. Ruoslahti.  Specialization of tumour vasculature , 2002, Nature Reviews Cancer.

[11]  C. T. Baillie,et al.  Tumour vasculature--a potential therapeutic target. , 1995, British Journal of Cancer.

[12]  H. W. Scheeren,et al.  Design, synthesis, and biological evaluation of a dual tumor-specific motive containing integrin-targeted plasmin-cleavable doxorubicin prodrug. , 2002, Molecular cancer therapeutics.

[13]  E. Ruoslahti,et al.  Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. , 1998, Science.

[14]  D. Melton,et al.  Endothelial signaling during development , 2003, Nature Medicine.

[15]  Peter S. Conti,et al.  Pegylated Arg-Gly-Asp Peptide: 64Cu Labeling and PET Imaging of Brain Tumor αvβ3-Integrin Expression , 2004 .